Statistics from Altmetric.com
A 48 year old man, a known diabetic for 14 years, who had poor compliance to treatment was admitted with left lower limb pain and deformity of his left foot for two months. He did not have a history of alcohol intake or promiscuity. On evaluation, he had bilateral loss of pain, touch, temperature, and vibration sense below the ankle joint. His vibration perception threshold was increased to 46 mV on the left side and 38 mV on the right side (normal <25 mV). The pressure sense tested with a SG 5.07 monofilament over both feet was impaired and he had “rocker bottom type deformity” of the left foot (fig 1). His body mass index was 24 kg/m2. He was hypertensive and had bilateral advanced non-proliferative diabetic retinopathy. On investigation, random blood glucose was 26 mmol/l, serum creatinine 3.1 μmol/l, and 24 hour urine protein was 6.4 g. His Venereal Disease Research Laboratory test was negative and he had a normal total leucocyte count and erythrocyte sedimentation rate. Radiography of the left foot was suggestive of Charcot’s foot (fig 2). 99mTc methylene diphosphonate (MDP) bone scan showed increased tracer uptake in the region of the left foot suggestive of increased osteoblastic activity (fig 3). Magnetic resonance imaging (MRI) of the left foot revealed diffuse soft tissue oedema with maintained subcutaneous fat and disorganised and malaligned tarsal bones. Subchondrial cyst, marrow oedema, and inferior displacement of cuboid (fig 4) were additional features. The overall picture was of chronic neuroarthropathic joint due to diabetes mellitus. He was advised to have a total contact cast followed by special footwear. Additionally calcium, vitamin D, and alendronate 40 mg per day were prescribed. Bisphosphonates have been used in the treatment of Charcot’s foot because increased osteoclastic activity secondary to autonomic dysfunctions has been documented. Calcium and vitamin D were started to prevent bisphosphonate induced osteomalacia. Realignment surgery is planned.